GlassScriptPhysician profile
Mario A Cala
NPI 1316234024
$540,989.75
in general payments reported to CMS, 2019-2025
52 companies · $103K in 2025
The $103K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $74K · 2020: $6,330 · 2021: $65K · 2022: $119K · 2023: $65K · 2024: $108K · 2025: $103K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $158K · Royalty Or License: $63K · Travel and Lodging: $29K · Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $158,047.50 |
| Royalty Or License | $62,563.26 |
| Travel and Lodging | $29,056.00 |
| Food and Beverage | $15,561.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $323,357.87 | 2019-2025 | Hoffmann, Salvation, Prostep |
| Vilex LLC | $113,784.83 | 2021-2025 | Redemption |
| Wright Medical Technology, INC. | $72,783.07 | 2019-2020 | |
| Organogenesis INC. | $12,969.08 | 2020-2025 | Puraply Wound Matrix, Puraply Antimicrobial, Puraply |
| Musculoskeletal Transplant Foundation INC. | $2,959.35 | 2019-2022 | |
| Kerecis Limited | $2,836.59 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medical Device Business Services, INC. | $2,380.00 | 2020 | |
| Smith+Nephew, INC. | $2,227.59 | 2019-2025 | Grafix Pl, Collagenase Santyl, Regranex |
| Misonix INC | $1,855.45 | 2019-2021 | |
| Sanara Medtech INC. | $1,070.77 | 2022-2025 | Allocyte Plus, Celleraterx, Celleraterx |
| Integra Lifesciences Corporation | $574.00 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Next Science LLC | $365.04 | 2023-2024 | Blastx, Xperience, Surgx |
| Biocomposites INC | $334.08 | 2019-2022 | |
| Acera Surgical, INC. | $322.80 | 2022-2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $276.12 | 2019-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $246.01 | 2022-2025 | Trauma |
| Aroa Biosurgery Incorporated | $241.56 | 2024 | |
| Treace Medical Concepts, INC. | $231.72 | 2022 | |
| Innovation Technologies INC | $198.87 | 2025 | Irrisept |
| Linvatec Corporation | $193.84 | 2023-2024 | Allograft Tissue, Quantum, Neospan Superelastic Compression Staple W/Instruments, Size 10x10x10 |
| Medshape, INC. | $190.46 | 2024 | Dynanail |
| Bioventus LLC | $158.15 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Biotissue Holdings INC. | $138.58 | 2024-2025 | |
| Nextremity Solutions INC. | $138.20 | 2019 | |
| Urgo Medical North America, LLC | $134.35 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Bone Support INC. | $133.34 | 2024 | Ceramentbone Void Filler, Cerament G |
| Polynovo North America LLC | $85.27 | 2025 | Novosorb Btm |
| Teleflex LLC | $72.58 | 2024-2025 | Arrow, Quikclot, Quikclot |
| Cardiovascular Systems INC. | $67.33 | 2019-2020 | |
| Stimwave Technologies Incorporated | $58.51 | 2021 | |
| Curonix LLC | $48.15 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medela LLC | $44.50 | 2019 | |
| Omeza LLC | $40.51 | 2023 | |
| Amniox Medical, INC. | $36.83 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $35.34 | 2022 | |
| Highridge Medical LLC | $35.10 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $35.10 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Grt US Holding, INC. | $31.30 | 2021 | |
| Melinta Therapeutics, LLC | $30.39 | 2019 | |
| Mimedx Group, INC. | $30.36 | 2024-2025 | |
| Ets Wound Care LLC | $29.81 | 2025 | Mirragen Advanced Wound Matrix |
| Alexion Pharmaceuticals, INC. | $28.43 | 2019 | |
| Crossroads Extremity Systems, LLC | $26.09 | 2019 | |
| Amgen INC. | $25.06 | 2024 | Krystexxa |
| Abbott Laboratories | $21.81 | 2023 | Proclaim |
| Djo, LLC | $21.31 | 2025 | Cmf |
| Kowa Pharmaceuticals America, INC. | $16.95 | 2023 | Seglentis |
| Embody, INC. | $16.04 | 2021 | |
| Kci USA, INC. | $14.03 | 2022 | |
| Dynasplint Systems INC. | $13.13 | 2019 | |
| Zimvie INC. | $12.74 | 2023 | |
| Covidien LP | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$330.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Cala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.